Your browser doesn't support javascript.
Regulatory pathways and federal perspectives on nanoparticles
Nanoparticle Therapeutics: Production Technologies, Types of Nanoparticles, and Regulatory Aspects ; : 563-579, 2022.
Article in English | Scopus | ID: covidwho-2048736
ABSTRACT
A narrative intended for science interns and scientists to overview regulatory pathways and federal perspectives pertinent to the complexity of nanoparticle systems and chaos precipitated by the COVID-19 pandemic. It elaborates on fundamental aspects of US FDA guidance on nanotechnology. It juxtaposes guidance on nanotechnology with the COVID-19 guidance documents to get a deeper understanding of “good practices” in the context of professional response in chaotic, complex, complicated, and simple systems. The narrative spirals in on practical consideration for experiential learning to be self-assured. © 2022 Elsevier Inc. All rights reserved.
Keywords

Full text: Available Collection: Databases of international organizations Database: Scopus Language: English Journal: Nanoparticle Therapeutics: Production Technologies, Types of Nanoparticles, and Regulatory Aspects Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Scopus Language: English Journal: Nanoparticle Therapeutics: Production Technologies, Types of Nanoparticles, and Regulatory Aspects Year: 2022 Document Type: Article